Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT01609166
Eligibility Criteria:
Inclusion Criteria:
* Patients older than 18years-old,that initiate treatment with oral capecitabine, without signs of hand-feet syndrome toxicity.
* Free acceptance to participate part in this clinical trial, with signature of the form of informed assent approved for the study, writing of the volunteer.
Exclusion Criteria:
* Age lower than 18 years
* Precedents of allergy, idiosyncrasy or hypersensitivity to the medicament.
* Denial of the patient to sign the informed assent.
* Any disorder or current / previous treatment that, in the opinion of the investigator, incapacitates the patient to take part in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01609166
Study Brief:
Protocol Section:
NCT01609166